The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Quantification of risk factors for herpes zoster: population based case-control study
Open accessAbstract
OBJECTIVES: To quantify the effects of possible risk factors for herpes zoster at different ages. DESIGN: Case-control study. SETTING: UK Clinical Practice Research Datalink primary care data. PARTICIPANTS: 144 959 adults diagnosed with zoster between 2000 and 2011; 549,336 age, sex, and practice matched controls. MAIN OUTCOME MEASURES: Conditional logistic regression was used to generate adjusted odds ratios to estimate the strength of association of each potential risk factor with zoster and assess effect modification by age. RESULTS: The median age of the cases and controls was 62 years. Factors associated with increased risk of zoster included rheumatoid arthritis (3111 (2.1%) v 8029 (1.5%); adjusted odds ratio 1.46, 99% confidence interval 1.38 to 1.55), inflammatory bowel disease (1851 (1.3%) v 5118 (0.9%); 1.36, 1.26 to 1.46), chronic obstructive pulmonary disease (6815 (4.7%) v 20 201 (3.7%); 1.32, 1.27 to 1.37), asthma (10 243 (7.1%) v 31 865 (5.8%); 1.21, 1.17 to 1.25), chronic kidney disease (8724 (6.0%) v 29 437 (5.4%); 1.14, 1.09 to 1.18), and depression (6830 (4.7%) v 22 052 (4.0%); 1.15, 1.10 to 1.20). Type 1, but not type 2, diabetes showed some association with zoster (adjusted odds ratio 1.27, 1.07 to 1.50). The relative effects of many assessed risk factors were larger in younger patients. Patients with severely immunosuppressive conditions were at greatest risk of zoster-for example, patients with lymphoma (adjusted odds ratio 3.90, 3.21 to 4.74) and myeloma (2.16, 1.84 to 2.53), who are not eligible for zoster vaccination. CONCLUSIONS: A range of conditions were associated with increased risk of zoster. In general, the increased risk was proportionally greater in younger age groups. Current vaccines are contraindicated in people at the greatest risk of zoster, highlighting the need for alternative risk reduction strategies in these groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,386
Immune dysfunction in patients with diabetes mellitus (DM)
Geerlings, S. (1999) · FEMS Immunology and Medical Microbiology · doi:10.1016/s0928-8244(99)00142-x · Cited by 1,272
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · PubMed · Cited by 1,037
Role of deficient type III interferon-λ production in asthma exacerbations
Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1462 · Cited by 1,006
Corticosteroid‐Mediated Immunoregulation in Man
Cupps, T. R., & Fauci, A. S. (1982) · Immunological Reviews · doi:10.1111/j.1600-065x.1982.tb00431.x · Cited by 887
Gnann, J. W., & Whitley, R. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013211 · Cited by 781
New insights into the immunology of chronic obstructive pulmonary disease
Brusselle, G. G., Joos, G. F., & Bracke, K. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60988-4 · Cited by 776
What does epidemiology tell us about risk factors for herpes zoster?
Thomas, S. L., & Hall, A. J. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00857-0 · Cited by 561
Self-citationInhaled corticosteroids for stable chronic obstructive pulmonary disease
Yang, I. A., Clarke, M. S., Sim, E. H., & Fong, K. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002991.pub3 · Cited by 523
Lewis, J. D., Bilker, W. B., Weinstein, R. B., & Strom, B. L. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1115 · Cited by 341
Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom
GAUTHIER, A., BREUER, J., CARRINGTON, D., MARTIN, M., & RÉMY, V. (2009) · Epidemiology and Infection · doi:10.1017/s0950268808000678 · Cited by 287
Smitten, A. L., Choi, H. K., Hochberg, M. C., Suissa, S., Simon, T. A., Testa, M. A., & Chan, K. A. (2007) · Arthritis Care & Research · doi:10.1002/art.23112 · Cited by 281
What Does the Odds Ratio Estimate in a Case-Control Study?
PEARCE, N. (1993) · International Journal of Epidemiology · doi:10.1093/ije/22.6.1189 · Cited by 266
Risk Factors for Postherpetic Neuralgia
Choo, P. W. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.11.1217 · Cited by 229
Opstelten, W. (2002) · Family Practice · doi:10.1093/fampra/19.5.471 · Cited by 228
RODRIGUES, L., & KIRKWOOD, B. R. (1990) · International Journal of Epidemiology · doi:10.1093/ije/19.1.205 · Cited by 207
Langan, S. M., Smeeth, L., Margolis, D. J., & Thomas, S. L. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001420 · Cited by 203
Self-citationIncreased risk of herpes zoster among 108 604 patients with inflammatory bowel disease
Long, M. D., Martin, C., Sandler, R. S., & Kappelman, M. D. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12182 · Cited by 186
Hope-Simpson, R. E. (1975) · PubMed · Cited by 172
Characteris Tics and Causes of Immune Dysfunction Related to Uremia and Dialysis
Hauser, A. B., Stinghen, A. E. M., Kato, S., Bucharles, S., Aita, C., Yuzawa, Y., & Pecoits–Filho, R. (2008) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.1177/089686080802803s34 · Cited by 169
Dworkin, R. H., Hartstein, G., Rosner, H. L., Walther, R. R., Sweeney, E. W., & Brand, L. (1992) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.101.1.200 · Cited by 159
Diabetes and ethnic minorities
Oldroyd, J., Banerjee, M., Heald, A., & Cruickshank, K. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.029124 · Cited by 159
Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales
van Hoek, A. J., Gay, N., Melegaro, A., Opstelten, W., & Edmunds, W. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.12.024 · Cited by 156
Diabetes as a Risk Factor for Herpes Zoster Infection: Results of a Population-Based Study in Israel
Heymann, A. D., Chodick, G., Karpati, T., Kamer, L., Kremer, E., Green, M. S., Kokia, E. S., & Shalev, V. (2008) · Infection · doi:10.1007/s15010-007-6347-x · Cited by 138
Predictors of Postherpetic Neuralgia Among Patients With Herpes Zoster: A Prospective Study
Drolet, M., Brisson, M., Schmader, K. E., Levin, M. J., Johnson, R. W., Oxman, M. N., Patrick, D. M., Camden, S., & Mansi, J. A. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.02.020 · Cited by 128
Epidemiological Features and Costs of Herpes Zoster in Taiwan: a National Study 2000 to 2006
Jih, J., Chen, Y., Lin, M., Chen, Y., Chen, T., Huang, Y., Chen, C., Lee, D.-D., Chang, Y., Wang, W., et al. (2009) · Acta Dermato Venereologica · doi:10.2340/00015555-0729 · Cited by 122
Gebo, K. A., Kalyani, R. R., Moore, R. D., & Polydefkis, M. J. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000178408.62675.b0 · Cited by 119
Cellular Immunity to Varicella‐Zoster Virus in Patients with Major Depression
Irwin, M. R., Costlow, C., Williams, H., Artin, K. H., Chan, C. Y., Stinson, D., Levin, M. J., Hayward, A. R., & Oxman, M. N. (1998) · The Journal of Infectious Diseases · doi:10.1086/514272 · Cited by 115
Lu, P.-J., Euler, G. L., Jumaan, A. O., & Harpaz, R. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.077 · Cited by 111
Incidence and Time Trends of Herpes Zoster in Rheumatoid Arthritis: A Population‐Based Cohort Study
Veetil, B. M. A., Myasoedova, E., Matteson, E. L., Gabriel, S. E., Green, A. B., & Crowson, C. S. (2012) · Arthritis Care & Research · doi:10.1002/acr.21928 · Cited by 108
Time-window Bias in Case-control Studies
Suissa, S., Dell’Aniello, S., Vahey, S., & Renoux, C. (2011) · Epidemiology · doi:10.1097/ede.0b013e3182093a0f · Cited by 105
Chronic Medical Conditions as Risk Factors for Herpes Zoster
Joesoef, R. M., Harpaz, R., Leung, J. W. T., & Bialek, S. R. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.05.021 · Cited by 105
Yang, Y., Chen, Y.-H., Wang, K.-H., Wang, C., & Lin, H.-W. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101137 · Cited by 99
Herpes Zoster Among Persons Living With HIV in the Current Antiretroviral Therapy Era
Blank, L. J., Polydefkis, M. J., Moore, R. D., & Gebo, K. A. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318266cd3c · Cited by 85
Stressor-lnduced Alterations of Immune Function: Mechanisms and Issues
Kusnecov, A. W., & Rabin, B. S. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236812 · Cited by 85
Irwin, M. R., Levin, M. J., Laudenslager, M. L., Olmstead, R., Lucko, A., Lang, N., Carrillo, C., Stanley, H. A., Caulfield, M. J., Weinberg, A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis1208 · Cited by 81
Rübben, A., Baron, J. M., & Grußendorf-Conen, E.-I. (1997) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1997.18161913.x · Cited by 77
Katz, J., McDermott, M., Cooper, E. M., Walther, R. R., Sweeney, E. W., & Dworkin, R. H. (2005) · Journal of Pain · doi:10.1016/j.jpain.2005.07.006 · Cited by 66
Risk of Herpes Zoster in CKD: A Matched-Cohort Study Based on Administrative Data
Wu, M., Hsu, Y., Su, C.-L., Lin, Y., & Lin, H. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.03.018 · Cited by 58
Risk of Herpes Zoster in Patients Treated With Long-term Hemodialysis: A Matched Cohort Study
Kuo, C.-C., Lee, C., Lee, I., Ho, S., & Yang, C. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.10.049 · Cited by 56
Clinical Diagnosis of Herpes Zoster in Family Practice
Opstelten, W., van Loon, A. M., Schüller, M., van Wijck, A. J. M., van Essen, G. A., Moons, K. G. M., & Verheij, T. J. (2007) · The Annals of Family Medicine · doi:10.1370/afm.707 · Cited by 56
Increased Risk of Herpes Zoster in Children with Asthma: A Population-Based Case-Control Study
Kim, B.-S., Mehra, S., Yawn, B. P., Grose, C. F., Tarrell, R. F., Lahr, B. D., & Juhn, Y. J. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.03.010 · Cited by 52
Safety and tolerability of a high-potency zoster vaccine in adults ≥50 years of age
Tyring, S. K., Díaz‐Mitoma, F., Padget, L. G., Nunez, M., Poland, G. A., Cassidy, W. M., Bundick, N. D., Li, J., Chan, I. S. F., Stek, J. E., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.10.027 · Cited by 41
Herpes zoster and HIV-1 infection in a rural Ugandan cohort
Morgan, D., Mahé, C., Malamba, S. S., Okongo, M. J., Mayanja, B. N., & Whitworth, J. A. G. (2001) · AIDS · doi:10.1097/00002030-200101260-00012 · Cited by 34
Risk of herpes zoster among patients with psychiatric diseases: a population‐based study
Yang, Y., Chen, Y., & Lin, H. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03811.x · Cited by 22
Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study
Ernst, P., Dell’Aniello, S., Mikaeloff, Y., & Suissa, S. (2011) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-11-59 · Cited by 22
Predictive Factors for Postherpetic Neuralgia Using Ordered Logistic Regression Analysis
Kanbayashi, Y., Onishi, K., Fukazawa, K., Okamoto, K., Ueno, H., Takagi, T., & Hosokawa, T. (2011) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318243ee01 · Cited by 22
Cited by
Varicella zoster virus infection
Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C., Hambleton, S., Kennedy, P. G. E., Oxman, M. N., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.16 · Cited by 910
Risk Factors for Herpes Zoster Infection: A Meta-Analysis
Marra, F., Parhar, K., Huang, B., & Vadlamudi, N. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa005 · Cited by 335
Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis
Kawai, K., & Yawn, B. P. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.10.009 · Cited by 310
Johnson, R. W., Alvarez-Pasquin, M.-J., Bijl, M., Franco, E., Gaillat, J., Clara, J. G., Labetoulle, M., Michel, J.-P., Naldi, L., Sanmarti, L. S., et al. (2015) · Therapeutic Advances in Vaccines · doi:10.1177/2051013615599151 · Cited by 288
Bechman, K., Subesinghe, S., Norton, S., Atzeni, F., Galli, M., Cope, A. P., Winthrop, K. L., & Galloway, J. B. (2019) · Rheumatology · doi:10.1093/rheumatology/kez087 · Cited by 287
Metadata
- Authors
- Forbes, H. J., Bhaskaran, K., Thomas, S. L., Smeeth, L., Clayton, T., & Langan, S. M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2014-05-13
- Volume
- 348
- Pages
- g2911
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2164587440
- Cited by
- 267
- References
- 49
- FWCI
- 13.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.